GEN Article: Supercharge Antibody Discovery Workflows with High-Throughput SPR
PerkinElmer Invests in Carterra, the Leader in Label-Free High Throughput Antibody Screening and Characterization
Carterra® Announces the Appointment of Joseph D. Keegan, PhD as Executive Chairman of the Board of Directors
Carterra® Announces Successful Immunity Monitoring of COVID-19 Patients Using a SARS-CoV-2 Label-free Assay
GEN Article: Eliminating Bottlenecks in mAb Drug Discovery
Twist Biopharma screens massive antibody libraries with the Carterra LSA to discover therapeutic antibodies in just weeks.
Podcast: Tim Germann our Chief Commercial Officer Discusses how Carterra has Become an Innovator and Driving Force in Therapeutic Antibody Discovery
Nature Article: Speeding Antibody Screening for Drug Development
Advanced screening technology can dramatically accelerate the hunt for effective treatments for cancer, COVID-19 and more.
Video: Carterra has been Selected by the Gates Foundation to Help Solve the COVID-19 Pandemic
Carterra® Inc. Selected by the La Jolla Institute of Immunology to Provide Antibody Screening and Characterization for the Coronavirus Immunotherapy Consortium (CoVIC)
Biocompare Article on How Epitope Binning Streamlines Discovery and Exploits Diversity
Epitope binning screens and characterizes antibodies in one step. Studying kinetics, affinity, and epitope relationships in high throughput allows characterization of antibody libraries generated against a specific antigen through B cell cloning, phage display, or hybridoma technologies.